Gyre Therapeutics, Inc. GYRE All Other Segments — Operating Expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s all other segments — operating expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s all other segments — operating expenses?
- Gyre Therapeutics, Inc. (GYRE) reported all other segments — operating expenses of $6K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s all other segments — operating expenses changed year-over-year?
- Gyre Therapeutics, Inc.'s all other segments — operating expenses increased by 100.0% year-over-year, from $3K to $6K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s all other segments — operating expenses?
- Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s all other segments — operating expenses has grown at a -61.8% compound annual growth rate (CAGR), from $130K to $19K.
- What does all other segments — operating expenses mean?
- This metric aggregates all costs associated with the day-to-day operations of the 'All Other Segments' business unit, including selling, general, administrative, and research expenses. It serves as a comprehensive measure of the total operational burden required to run these specific business activities. Comparing this to segment revenue helps determine the operational leverage of the segment.